Marvion Inc. Enters $200,000 Stock Purchase Agreement to Strengthen Capital Base and Support Strategic Growth

Marvion Inc. Enters $200,000 Stock Purchase Agreement to Strengthen Capital Base and Support Strategic Growth

HONG KONG, Jan. 19, 2026 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC) (the "Company" or "Marvion") announced today that it has entered into a stock purchase agreement with third-party investor Ray Mak Pak Fai (the "Investor"). Under the agreement, the...

FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene's NouvNeu001, Making It the World's First iPSC Therapy with Both FTD and RMAT Recognitions

FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene's NouvNeu001, Making It the World's First iPSC Therapy with Both FTD and RMAT Recognitions

Designation underscores potential of chemically induced, off-the-shelf cell therapy to address high unmet need in Parkinson's disease, following compelling Phase I clinical data CHENGDU, China, Jan. 19, 2026 /PRNewswire/ -- iRegene Therapeutics Co.,...

e& and IBM Unveil Enterprise-Grade Agentic AI to Transform Governance and Compliance

e& and IBM Unveil Enterprise-Grade Agentic AI to Transform Governance and Compliance

Announced at the World Economic Forum in Davos, the deployment marks e&'s move beyond traditional chatbots to enterprise-grade agentic AI. Powered by IBM watsonx Orchestrate, agentic AI is embedded into mission-critical governance and compliance...

NOVEON MAGNETICS COMPLETES $215 MILLION SERIES C TO EXPAND U.S. RARE EARTH MAGNET MANUFACTURING CAPACITY

NOVEON MAGNETICS COMPLETES $215 MILLION SERIES C TO EXPAND U.S. RARE EARTH MAGNET MANUFACTURING CAPACITY

Financing Round Led by One Investment Management Supports Expansion of Domestic Rare Earth Magnet Production and Facilitates Secondary Share Sale SAN MARCOS, Texas, Jan. 19, 2026 /PRNewswire/ -- Noveon Magnetics, Inc. (Noveon), a leading U.S....

6Letters Launches "MOJO KING," an Apple Watch-Based iOS App for Non-Invasive Testosterone Monitoring

6Letters Launches "MOJO KING," an Apple Watch-Based iOS App for Non-Invasive Testosterone Monitoring

SEOUL, South Korea, Jan. 19, 2026 /PRNewswire/ -- Digital healthcare startup 6Letters today announced the official launch of MOJO KING, an iOS application that enables non-invasive monitoring of testosterone-related physiological patterns using...

SUNRATE Announces New Alliance with International Travel Technology Provider Juniper Travel Technology

SUNRATE Announces New Alliance with International Travel Technology Provider Juniper Travel Technology

LONDON, Jan. 19, 2026 /PRNewswire/ -- SUNRATE, the global payment and treasury management platform, today announced a new alliance with international travel-technology provider Juniper Travel Technology, underscoring both companies' commitment to...

The Caravel Group Appoints Angad Banga as Group Chief Executive Officer

The Caravel Group Appoints Angad Banga as Group Chief Executive Officer

Planned Succession Positions Diversified Conglomerate for Continued Growth Dr. Harry S. Banga to continue leading the Group as Founder and Executive Chairman HONG KONG, Jan. 19, 2026 /PRNewswire/ -- The Caravel Group announced the appointment of Mr....

GCL SI Delivers Marine Floating Solar Solution in the Maldives, Enabling Island Energy Transition

GCL SI Delivers Marine Floating Solar Solution in the Maldives, Enabling Island Energy Transition

SUZHOU, China, Jan. 19, 2026 /PRNewswire/ -- GCL System Integration (GCL SI) has announced the successful completion of the joint floating solar energy project in collaboration with long-term partner Ocean Sun for the Soneva Secret resort in...

D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002

D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002

SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two...

Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration

Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and...

  • 1
  • ...
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • ...
  • 241
  • menu
    menu